- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01824875
Temozolomid s nebo bez kapecitabinu v léčbě pacientů s pokročilými neuroendokrinními nádory pankreatu
Randomizovaná studie fáze II temozolomidu nebo temozolomidu a kapecitabinu u pacientů s pokročilými neuroendokrinními nádory pankreatu
This randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether temozolomide is more effective with or without capecitabine in treating patients with advanced pancreatic neuroendocrine tumors.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
PRIMARY OBJECTIVES:
I. To evaluate progression-free survival (PFS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
SECONDARY OBJECTIVES:
I. To evaluate response rates (RR) associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
II. To evaluate overall survival (OS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
III. To evaluate the toxicity associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
IV. To evaluate the usefulness of methyl guanine methyltransferase (MGMT) status (by immunohistochemistry [IHC] and promoter methylation) for predicting response in pancreatic neuroendocrine tumor patients treated with either temozolomide or temozolomide and capecitabine.
V. To bank radiology images for evaluation of quality, reproducibility, and compliance with computed tomography (CT) methodology.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM A: Patients receive temozolomide orally (PO) once daily (QD) on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
ARM B: Patients receive capecitabine PO twice daily (BID) on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 2 years, and then every 6 months for 3 years.
Typ studie
Zápis (Aktuální)
Fáze
- Fáze 2
Kontakty a umístění
Studijní místa
-
-
California
-
Anaheim, California, Spojené státy, 92807
- Kaiser Anaheim Medical Center
-
Antioch, California, Spojené státy, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Baldwin Park, California, Spojené státy, 91706
- Kaiser Permanente Medical Group - Baldwin Park
-
Bellflower, California, Spojené státy, 90706
- Kaiser Foundation Hospital
-
Berkeley, California, Spojené státy, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Burlingame, California, Spojené státy, 94010
- Mills - Peninsula Hospitals
-
Fontana, California, Spojené státy, 92335
- Kaiser Permanente Hospital
-
Fremont, California, Spojené státy, 94538
- Kaiser Permanente, Fremont
-
Fresno, California, Spojené státy, 93720
- Kaiser Permanente
-
Harbor City, California, Spojené státy, 90710
- Kaiser Permanente - Harbor City
-
Hayward, California, Spojené státy, 94545
- Kaiser Permanente, Hayward
-
Irvine, California, Spojené státy, 92618
- Southern California Permanente Medical Group
-
Los Angeles, California, Spojené státy, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Spojené státy, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Spojené státy, 90033
- University of Southern California/Norris Cancer Center
-
Los Angeles, California, Spojené státy, 90034
- Kaiser Permanente-West Los Angeles
-
Modesto, California, Spojené státy, 95356
- Kaiser Permanente-Modesto
-
Novato, California, Spojené státy, 94945
- Sutter Cancer Research Consortium
-
Oakland, California, Spojené státy, 94611
- Kaiser Permanente-Oakland
-
Orange, California, Spojené státy, 92868
- University of California Medical Center At Irvine-Orange Campus
-
Panorama City, California, Spojené státy, 91402
- Kaiser Permanente - Panorama City
-
Redwood City, California, Spojené státy, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Spojené státy, 94801
- Kaiser Permanente-Richmond
-
Riverside, California, Spojené státy, 92505
- Kaiser Permanente Medical Center
-
Roseville, California, Spojené státy, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Spojené státy, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Spojené státy, 95825
- Kaiser Permanente - Sacramento
-
San Diego, California, Spojené státy, 92120
- Kaiser Permanente at San Diego
-
San Diego, California, Spojené státy, 92120
- Kaiser Permanente
-
San Francisco, California, Spojené státy, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Spojené státy, 94118
- California Pacific Medical Center
-
San Francisco, California, Spojené státy, 94115
- UCSF-Mount Zion
-
San Jose, California, Spojené státy, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Marcos, California, Spojené státy, 92069
- Kaiser Permanente Health Care
-
San Rafael, California, Spojené státy, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Spojené státy, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Spojené státy, 95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa, California, Spojené státy, 95403
- Sutter Pacific Medical Foundation
-
South San Francisco, California, Spojené státy, 94080
- Kaiser Permanente-South San Francisco
-
Stanford, California, Spojené státy, 94305
- Stanford University Hospitals and Clinics
-
Stockton, California, Spojené státy, 95210
- Kaiser Permanente-Stockton
-
Vacaville, California, Spojené státy, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Spojené státy, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Spojené státy, 94589
- Sutter Solano Medical Center
-
Walnut Creek, California, Spojené státy, 94596
- Kaiser Permanente-Walnut Creek
-
Woodland Hills, California, Spojené státy, 91367
- Kaiser Permanente
-
-
Connecticut
-
Hartford, Connecticut, Spojené státy, 06105
- Saint Francis Hospital and Medical Center
-
Middletown, Connecticut, Spojené státy, 06457
- Middlesex Hospital
-
-
Delaware
-
Lewes, Delaware, Spojené státy, 19958
- Beebe Medical Center
-
Newark, Delaware, Spojené státy, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Spojené státy, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Spojené státy, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Spojené státy, 19718
- Christiana Care Health System-Christiana Hospital
-
Newark, Delaware, Spojené státy, 19713
- Christiana Gynecologic Oncology LLC
-
Newark, Delaware, Spojené státy, 19713
- Regional Hematology and Oncology PA
-
Rehoboth Beach, Delaware, Spojené státy, 19971
- Beebe Health Campus
-
Seaford, Delaware, Spojené státy, 19973
- Nanticoke Memorial Hospital
-
Wilmington, Delaware, Spojené státy, 19801
- Christiana Care Health System-Wilmington Hospital
-
-
Florida
-
Jacksonville, Florida, Spojené státy, 32207
- Edna Williams Cancer Center at the Baptist Cancer Institute
-
Miami, Florida, Spojené státy, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Orlando, Florida, Spojené státy, 32803
- Florida Hospital
-
Tampa, Florida, Spojené státy, 33612
- H. Lee Moffitt Cancer Center and Research Institute
-
-
Hawaii
-
Honolulu, Hawaii, Spojené státy, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Spojené státy, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Spojené státy, 96819
- Kaiser Permanente Moanalua Medical Center
-
Honolulu, Hawaii, Spojené státy, 96813
- University of Hawaii
-
Honolulu, Hawaii, Spojené státy, 96813
- Oncare Hawaii Inc-POB II
-
Honolulu, Hawaii, Spojené státy, 96817-3169
- OnCare Hawaii-Liliha
-
Honolulu, Hawaii, Spojené státy, 96817
- Oncare Hawaii Inc-Kuakini
-
Kailua, Hawaii, Spojené státy, 96734
- Castle Medical Center
-
Lihue, Hawaii, Spojené státy, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Spojené státy, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Spojené státy, 96701
- Oncare Hawaii Inc-Pali Momi
-
-
Idaho
-
Boise, Idaho, Spojené státy, 83706
- Saint Alphonsus Regional Medical Center
-
-
Illinois
-
Bloomington, Illinois, Spojené státy, 61701
- Saint Joseph Medical Center
-
Bloomington, Illinois, Spojené státy, 61701
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Spojené státy, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Spojené státy, 62902
- Memorial Hospital of Carbondale
-
Carthage, Illinois, Spojené státy, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Spojené státy, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Spojené státy, 60611
- Northwestern University
-
Chicago, Illinois, Spojené státy, 60612
- University of Illinois
-
Decatur, Illinois, Spojené státy, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Spojené státy, 62526
- Cancer Care Center of Decatur
-
Effingham, Illinois, Spojené státy, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Spojené státy, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Spojené státy, 61401
- Illinois CancerCare Galesburg
-
Galesburg, Illinois, Spojené státy, 61401
- Illinois CancerCare-Galesburg Cottage Plaza Office
-
Highland Park, Illinois, Spojené státy, 60035
- Hematology Oncology Associates of Illinois-Highland Park
-
Hinsdale, Illinois, Spojené státy, 60521
- Hinsdale Hematology Oncology Associates Incorporated
-
Kankakee, Illinois, Spojené státy, 60901
- Presence Saint Mary's Hospital
-
Kewanee, Illinois, Spojené státy, 61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville, Illinois, Spojené státy, 60048
- North Shore Hematology Oncology
-
Macomb, Illinois, Spojené státy, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Spojené státy, 60153
- Loyola University Medical Center
-
Moline, Illinois, Spojené státy, 61265
- Garneau, Stewart C MD (UIA Investigator)
-
Moline, Illinois, Spojené státy, 61265
- Porubcin, Michael MD (UIA Investigator)
-
Moline, Illinois, Spojené státy, 61265
- Spector, David MD (UIA Investigator)
-
Moline, Illinois, Spojené státy, 61265
- Trinity Medical Center
-
Monmouth, Illinois, Spojené státy, 61462
- Illinois CancerCare-Monmouth
-
Mount Vernon, Illinois, Spojené státy, 62864
- Good Samaritan Regional Health Center
-
Niles, Illinois, Spojené státy, 60714
- Illinois Cancer Specialists-Niles
-
Normal, Illinois, Spojené státy, 61761
- Community Cancer Center Foundation
-
Ottawa, Illinois, Spojené státy, 61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa, Illinois, Spojené státy, 61350
- Ottawa Regional Hospital and Healthcare Center
-
Pekin, Illinois, Spojené státy, 61554
- Pekin Cancer Treatment Center
-
Pekin, Illinois, Spojené státy, 61603
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Spojené státy, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Spojené státy, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Spojené státy, 61614
- Proctor Hospital
-
Peoria, Illinois, Spojené státy, 61603
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Spojené státy, 61615
- Illinois Oncology Research Association CCOP
-
Peru, Illinois, Spojené státy, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Spojené státy, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Spojené státy, 61107
- SwedishAmerican Regional Cancer Center/ACT
-
Skokie, Illinois, Spojené státy, 60076
- Hematology Oncology Associates of Illinois - Skokie
-
Springfield, Illinois, Spojené státy, 62781-0001
- Memorial Medical Center
-
-
Indiana
-
Indianapolis, Indiana, Spojené státy, 46237
- Franciscan Saint Francis Health-Indianapolis
-
Richmond, Indiana, Spojené státy, 47374
- Reid Hospital and Health Care Services
-
-
Iowa
-
Ames, Iowa, Spojené státy, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Spojené státy, 50010
- McFarland Clinic PC-William R Bliss Cancer Center
-
Bettendorf, Iowa, Spojené státy, 52722
- Constantinou, Costas L MD (UIA Investigator)
-
Boone, Iowa, Spojené státy, 50036
- McFarland Clinic PC-Boone
-
Clive, Iowa, Spojené státy, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Spojené státy, 50325
- Medical Oncology and Hematology Associates-West Des Moines
-
Des Moines, Iowa, Spojené státy, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Spojené státy, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Spojené státy, 50309
- Medical Oncology and Hematology Associates-Des Moines
-
Des Moines, Iowa, Spojené státy, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Spojené státy, 50314
- Medical Oncology and Hematology Associates-Laurel
-
Des Moines, Iowa, Spojené státy, 50309
- Iowa Oncology Research Association CCOP
-
Jefferson, Iowa, Spojené státy, 50129
- McFarland Clinic PC-Jefferson
-
Marshalltown, Iowa, Spojené státy, 50158
- McFarland Clinic PC-Marshalltown
-
Sioux City, Iowa, Spojené státy, 51104
- Saint Luke's Regional Medical Center
-
Sioux City, Iowa, Spojené státy, 51101
- Siouxland Hematology Oncology Associates
-
Sioux City, Iowa, Spojené státy, 51104
- Mercy Medical Center-Sioux City
-
West Des Moines, Iowa, Spojené státy, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Spojené státy, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Chanute, Kansas, Spojené státy, 66720
- Cancer Center of Kansas - Chanute
-
Dodge City, Kansas, Spojené státy, 67801
- Cancer Center of Kansas - Dodge City
-
El Dorado, Kansas, Spojené státy, 67042
- Cancer Center of Kansas - El Dorado
-
Fort Scott, Kansas, Spojené státy, 66701
- Cancer Center of Kansas - Fort Scott
-
Independence, Kansas, Spojené státy, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, Spojené státy, 67068
- Cancer Center of Kansas-Kingman
-
Lawrence, Kansas, Spojené státy, 66044
- Lawrence Memorial Hospital
-
Liberal, Kansas, Spojené státy, 67901
- Cancer Center of Kansas-Liberal
-
Manhattan, Kansas, Spojené státy, 66502
- Cancer Center of Kansas-Manhattan
-
McPherson, Kansas, Spojené státy, 67460
- Cancer Center of Kansas - McPherson
-
Newton, Kansas, Spojené státy, 67114
- Cancer Center of Kansas - Newton
-
Parsons, Kansas, Spojené státy, 67357
- Cancer Center of Kansas - Parsons
-
Pratt, Kansas, Spojené státy, 67124
- Cancer Center of Kansas - Pratt
-
Salina, Kansas, Spojené státy, 67401
- Cancer Center of Kansas - Salina
-
Wellington, Kansas, Spojené státy, 67152
- Cancer Center of Kansas - Wellington
-
Wichita, Kansas, Spojené státy, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Spojené státy, 67208
- Associates In Womens Health
-
Wichita, Kansas, Spojené státy, 67214
- Cancer Center of Kansas - Main Office
-
Wichita, Kansas, Spojené státy, 67214
- Via Christi Regional Medical Center
-
Wichita, Kansas, Spojené státy, 67214
- Wichita CCOP
-
Winfield, Kansas, Spojené státy, 67156
- Cancer Center of Kansas - Winfield
-
-
Kentucky
-
Crestview Hills, Kentucky, Spojené státy, 41017
- Oncology Hematology Care Incorporated
-
-
Louisiana
-
Baton Rouge, Louisiana, Spojené státy, 70809
- Ochsner Health Center-Summa
-
New Orleans, Louisiana, Spojené státy, 70121
- Ochsner Medical Center Jefferson
-
-
Massachusetts
-
Boston, Massachusetts, Spojené státy, 02118
- Boston Medical Center
-
Burlington, Massachusetts, Spojené státy, 01805
- Lahey Hospital and Medical Center
-
-
Michigan
-
Adrian, Michigan, Spojené státy, 49221
- Bixby Medical Center
-
Adrian, Michigan, Spojené státy, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Spojené státy, 48106-0995
- Saint Joseph Mercy Hospital
-
Ann Arbor, Michigan, Spojené státy, 48106
- Michigan Cancer Research Consortium Community Clinical Oncology Program
-
Ann Arbor, Michigan, Spojené státy, 48109
- University of Michigan University Hospital
-
Dearborn, Michigan, Spojené státy, 48124
- Oakwood Hospital
-
Detroit, Michigan, Spojené státy, 48236
- Saint John Hospital and Medical Center
-
Flint, Michigan, Spojené státy, 48502
- Hurley Medical Center
-
Flint, Michigan, Spojené státy, 48503
- Genesys Hurley Cancer Institute
-
Jackson, Michigan, Spojené státy, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Spojené státy, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Spojené státy, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Spojené státy, 49001
- Borgess Medical Center
-
Lansing, Michigan, Spojené státy, 48912
- Sparrow Hospital
-
Livonia, Michigan, Spojené státy, 48154
- Saint Mary Mercy Hospital
-
Monroe, Michigan, Spojené státy, 48162
- Mercy Memorial Hospital
-
Monroe, Michigan, Spojené státy, 48162
- Community Cancer Center of Monroe
-
Pontiac, Michigan, Spojené státy, 48341-2985
- Saint Joseph Mercy Oakland
-
Port Huron, Michigan, Spojené státy, 48060
- Saint Joseph Mercy Port Huron
-
Saginaw, Michigan, Spojené státy, 48601
- Saint Mary's of Michigan
-
Warren, Michigan, Spojené státy, 48093
- Saint John Macomb-Oakland Hospital
-
-
Minnesota
-
Burnsville, Minnesota, Spojené státy, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Spojené státy, 55433
- Mercy Hospital
-
Edina, Minnesota, Spojené státy, 55435
- Fairview-Southdale Hospital
-
Fridley, Minnesota, Spojené státy, 55432
- Unity Hospital
-
Hutchinson, Minnesota, Spojené státy, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, Spojené státy, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Spojené státy, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Spojené státy, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Spojené státy, 55407
- Abbott-Northwestern Hospital
-
New Ulm, Minnesota, Spojené státy, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Spojené státy, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Spojené státy, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, Spojené státy, 55416
- Metro-Minnesota CCOP
-
Saint Paul, Minnesota, Spojené státy, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Spojené státy, 55102
- United Hospital
-
Shakopee, Minnesota, Spojené státy, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Spojené státy, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Spojené státy, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Spojené státy, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Spojené státy, 55125
- Minnesota Oncology and Hematology PA-Woodbury
-
-
Missouri
-
Bolivar, Missouri, Spojené státy, 65613
- Central Care Cancer Center-Carrie J Babb Cancer Center
-
Branson, Missouri, Spojené státy, 65616
- CoxHealth Cancer Center
-
Cape Girardeau, Missouri, Spojené státy, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Spojené státy, 63703
- Southeast Cancer Center
-
Jefferson City, Missouri, Spojené státy, 65109
- Capital Region Medical Center-Goldschmidt Cancer Center
-
Rolla, Missouri, Spojené státy, 65401
- Phelps County Regional Medical Center
-
Rolla, Missouri, Spojené státy, 65401
- Saint John's Clinic-Rolla-Cancer and Hematology
-
Springfield, Missouri, Spojené státy, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Spojené státy, 65804
- Mercy Hospital Springfield
-
Springfield, Missouri, Spojené státy, 65802
- Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
-
St Louis, Missouri, Spojené státy, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Spojené státy, 63109
- Saint Louis Cancer and Breast Institute-South City
-
St Louis, Missouri, Spojené státy, 63141
- Saint John's Mercy Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Spojené státy, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Las Vegas, Nevada, Spojené státy, 89106
- Nevada Cancer Research Foundation CCOP
-
-
New Jersey
-
Camden, New Jersey, Spojené státy, 08103
- Cooper Hospital University Medical Center
-
Mount Holly, New Jersey, Spojené státy, 08060
- Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
-
Voorhees Township, New Jersey, Spojené státy, 08043
- Virtua West Jersey Hospital Voorhees
-
-
New York
-
Albany, New York, Spojené státy, 12208
- New York Oncology Hematology PC -Albany Medical Center
-
Albany, New York, Spojené státy, 12206
- New York Oncology Hematology PC - Albany
-
Amsterdam, New York, Spojené státy, 12010
- New York Oncology Hematology PC - Amsterdam
-
Hudson, New York, Spojené státy, 12534
- New York Oncology Hematology PC-Hudson
-
Latham, New York, Spojené státy, 12110
- New York Oncology Hematology PC - Latham
-
Rexford, New York, Spojené státy, 12148
- New York Oncology Hematology PC - Rexford
-
Rochester, New York, Spojené státy, 14642
- University of Rochester
-
The Bronx, New York, Spojené státy, 10467-2490
- Montefiore Medical Center
-
The Bronx, New York, Spojené státy, 10461
- Montefiore Medical Center-Weiler Division
-
Troy, New York, Spojené státy, 12180
- New York Oncology Hematology PC - Troy
-
-
North Carolina
-
Kinston, North Carolina, Spojené státy, 28501
- Kinston Medical Specialists PA
-
Statesville, North Carolina, Spojené státy, 28677
- Iredell Memorial Hospital
-
-
Ohio
-
Akron, Ohio, Spojené státy, 44307
- Akron General Medical Center
-
Beachwood, Ohio, Spojené státy, 44122
- Cleveland Clinic Cancer Center Beachwood
-
Belpre, Ohio, Spojené státy, 45714
- Strecker Cancer Center-Belpre
-
Bowling Green, Ohio, Spojené státy, 43402
- Toledo Clinic Cancer Centers-Bowling Green
-
Chillicothe, Ohio, Spojené státy, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Spojené státy, 45267
- University of Cincinnati
-
Cincinnati, Ohio, Spojené státy, 45230
- Oncology Hematology Care Inc - Anderson
-
Cincinnati, Ohio, Spojené státy, 45236
- Oncology Hematology Care Inc - Kenwood
-
Cincinnati, Ohio, Spojené státy, 45219
- Oncology and Hematology Care Incorporated
-
Cincinnati, Ohio, Spojené státy, 45242
- Oncology and Hematology Care Inc - Blue Ash
-
Cincinnati, Ohio, Spojené státy, 45248
- Oncology Hematology Care Inc - Western Hills
-
Cleveland, Ohio, Spojené státy, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Spojené státy, 44195
- Cleveland Clinic Foundation
-
Columbus, Ohio, Spojené státy, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Spojené státy, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Spojené státy, 43210
- Ohio State University Medical Center
-
Columbus, Ohio, Spojené státy, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Spojené státy, 43228
- Doctors Hospital
-
Columbus, Ohio, Spojené státy, 43215
- Grant Medical Center
-
Columbus, Ohio, Spojené státy, 43222
- Mount Carmel Health Center West
-
Columbus, Ohio, Spojené státy, 43215
- Columbus CCOP
-
Dayton, Ohio, Spojené státy, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Spojené státy, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Spojené státy, 45415
- Samaritan North Health Center
-
Dayton, Ohio, Spojené státy, 45405
- Grandview Hospital
-
Dayton, Ohio, Spojené státy, 45420
- Dayton CCOP
-
Delaware, Ohio, Spojené státy, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Spojené státy, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, Spojené státy, 43015
- Grady Memorial Hospital
-
Elyria, Ohio, Spojené státy, 44035
- Mercy Cancer Center-Elyria
-
Elyria, Ohio, Spojené státy, 44035
- Hematology Oncology Center Incorporated
-
Fairfield, Ohio, Spojené státy, 45014
- Oncology Hematology Care Inc
-
Findlay, Ohio, Spojené státy, 45840
- Blanchard Valley Hospital
-
Franklin, Ohio, Spojené státy, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Spojené státy, 45331
- Wayne Hospital
-
Independence, Ohio, Spojené státy, 44131
- Cleveland Clinic Cancer Center Independence
-
Kettering, Ohio, Spojené státy, 45429
- Kettering Medical Center
-
Lancaster, Ohio, Spojené státy, 43130
- Fairfield Medical Center
-
Lancaster, Ohio, Spojené státy, 43130
- Lancaster Radiation Oncology
-
Lima, Ohio, Spojené státy, 45801
- Saint Rita's Medical Center
-
Lima, Ohio, Spojené státy, 45804
- Lima Memorial Hospital
-
Marietta, Ohio, Spojené státy, 45750
- Marietta Memorial Hospital
-
Maumee, Ohio, Spojené státy, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Spojené státy, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Mayfield Heights, Ohio, Spojené státy, 44124
- Hillcrest Hospital Cancer Center
-
Mount Vernon, Ohio, Spojené státy, 43050
- Knox Community Hospital
-
Newark, Ohio, Spojené státy, 43055
- Licking Memorial Hospital
-
Newark, Ohio, Spojené státy, 43055
- Newark Radiation Oncology
-
Oregon, Ohio, Spojené státy, 43616
- Saint Charles Hospital
-
Oregon, Ohio, Spojené státy, 43616
- Toledo Clinic Cancer Centers-Oregon
-
Portsmouth, Ohio, Spojené státy, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Spojené státy, 44870
- North Coast Cancer Care
-
Springfield, Ohio, Spojené státy, 45505
- Springfield Regional Medical Center
-
Strongsville, Ohio, Spojené státy, 44136
- Cleveland Clinic Cancer Center-Strongsville
-
Sylvania, Ohio, Spojené státy, 43560
- Flower Hospital
-
Tiffin, Ohio, Spojené státy, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Spojené státy, 43608
- Saint Vincent Mercy Medical Center
-
Toledo, Ohio, Spojené státy, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Toledo, Ohio, Spojené státy, 43614
- University of Toledo
-
Toledo, Ohio, Spojené státy, 43617
- Toledo Community Hospital Oncology Program CCOP
-
Toledo, Ohio, Spojené státy, 43606
- The Toledo Hospital/Toledo Children's Hospital
-
Toledo, Ohio, Spojené státy, 43623
- Mercy Saint Anne Hospital
-
Troy, Ohio, Spojené státy, 45373
- Upper Valley Medical Center
-
Wauseon, Ohio, Spojené státy, 43567
- Fulton County Health Center
-
Westerville, Ohio, Spojené státy, 43081
- Saint Ann's Hospital
-
Xenia, Ohio, Spojené státy, 45385
- Greene Memorial Hospital
-
Zanesville, Ohio, Spojené státy, 43701
- Genesis HealthCare System
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Spojené státy, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Spojené státy, 74146
- Tulsa Cancer Institute
-
-
Pennsylvania
-
Danville, Pennsylvania, Spojené státy, 17822-2001
- Geisinger Medical Center
-
Hazleton, Pennsylvania, Spojené státy, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Hershey, Pennsylvania, Spojené státy, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Lewisburg, Pennsylvania, Spojené státy, 17837
- Geisinger Medical Oncology at Evangelical Community Hospital
-
Philadelphia, Pennsylvania, Spojené státy, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Spojené státy, 19107
- Thomas Jefferson University Hospital
-
Pottsville, Pennsylvania, Spojené státy, 17901
- Geisinger Medical Oncology-Pottsville
-
State College, Pennsylvania, Spojené státy, 16801
- Geisinger Medical Group
-
West Reading, Pennsylvania, Spojené státy, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, Spojené státy, 18711
- Geisinger Wyoming Valley
-
-
South Carolina
-
Greenville, South Carolina, Spojené státy, 29605
- Greenville Health System Cancer Institute-Butternut
-
Greenville, South Carolina, Spojené státy, 29615
- Greenville Health System Cancer Institute/Greenville CCOP
-
Greer, South Carolina, Spojené státy, 29650
- Greenville Health System Cancer Institute-Greer
-
-
Tennessee
-
Nashville, Tennessee, Spojené státy, 37232-6838
- Vanderbilt Cancer Center
-
-
Virginia
-
Fredericksburg, Virginia, Spojené státy, 22401
- Fredericksburg Oncology Inc
-
-
Wisconsin
-
La Crosse, Wisconsin, Spojené státy, 54601
- Gundersen Lutheran
-
Madison, Wisconsin, Spojené státy, 53792
- University of Wisconsin Hospital and Clinics
-
Milwaukee, Wisconsin, Spojené státy, 53226
- Froedtert and the Medical College of Wisconsin
-
New Richmond, Wisconsin, Spojené státy, 54017
- Cancer Center of Western Wisconsin
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
-
Patient must have histologically or pathologically confirmed locally unresectable or metastatic low or intermediate grade pancreatic neuroendocrine tumor
-
Patient must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria; baseline measurements and evaluations of all sites of disease must be obtained <= 4 weeks prior to randomization and must be acquired by multiphasic CT or contrast magnetic resonance imaging (MRI)
-
Date of last documented disease progression must be within 12 months from date of randomization
-
Prior everolimus and/or sunitinib therapy is allowed, so long as it was discontinued >= 4 weeks prior to randomization
-
Concurrent somatostatin analogues are allowed provided that patients
- Have been on a stable dose for 8 weeks and
- Have documented disease progression on that dose
-
Chemoembolization is allowed if ≥ 4 weeks from study entry. There are 2 possible scenarios:
- If patient has hepatic disease only: they need to have progressed in the liver since chemoembolization and have measurable disease by RECIST 1.1 in order to be eligible.
- If patient has hepatic and extrahepatic disease: they will need to have progressed inside OR outside the liver and have measureable disease by RECIST 1.1 in order to be eligible.
-
Leukocytes >= 3,000/mm^3
-
Absolute neutrophil count >= 1,500/mm^3
-
Hemoglobin >= 9 g/dL
-
Platelets >= 100,000/mm^3
-
Total bilirubin <= institutional upper limit of normal (ULN) or <= 1.5 X institutional ULN (if the patient has liver metastases)
-
Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) <= 3 X institutional ULN or (<= 5 X institutional ULN if the patient has liver metastases)
-
Serum creatinine <= 1.5 X institutional ULN
-
Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1
-
Patient must have life expectancy >= 12 weeks all females of childbearing potential must have a blood test or urine study within =< 2 weeks prior to randomization to rule out pregnancy; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Women of childbearing potential and sexually active males must be strongly advised to use an accepted and effective method of contraception or to abstain from sexual intercourse for the duration of their participation in the study; should a woman become pregnant while participating in this study, she should inform her treating physician immediately; if a man impregnates a woman while participating in this study, he should inform his treating physician immediately
-
Patient must be able to swallow pills
-
Patient must be able to tolerate CT or magnetic resonance (MR) imaging including contrast agents as required for their treatment and the protocol
Exclusion Criteria:
-
Small cell carcinoma
-
Prior temozolomide, dacarbazine (DTIC), or capecitabine, or 5-FU (fluorouracil) therapy
-
Receiving any other investigational agents while on study treatment
-
Receiving Coumadin while on treatment; other anticoagulants are allowed
-
Patients with either clinically apparent central nervous system metastases or carcinomatous meningitis are ineligible
-
Active or uncontrolled infection or serious medical or psychiatric illness
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or capecitabine
-
Absorption issues that would limit the ability to absorb study agents
-
Patients with a history of the following within 12 months of study entry:
- Arterial thromboembolic events
- Unstable angina
- Myocardial Infarction
-
Symptomatic peripheral vascular disease
-
Patients with previous or concurrent malignancy; exceptions are made for patients who meet any of the following conditions:
- Non-melanoma skin cancer, in situ cervical cancer, or breast cancer in situ OR
- Prior malignancy completely excised or removed and patient has been continuously disease free for > 5 years OR
- Prior malignancy cured by non-surgical modalities and patient has been continuously disease free for > 5 years
-
Pregnant or breast-feeding
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Arm A (temozolomide)
Patients receive temozolomide PO QD on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Ostatní jména:
|
|
Experimentální: Arm B (temozolomide and capecitabine)
Patients receive capecitabine PO BID on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Ostatní jména:
Given PO
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Progression-free Survival
Časové okno: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Progression-free survival (PFS) is defined as the time from randomization to progression or death without evidence of progression. Progression was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. Kaplan-Meier method was used to estimate PFS. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Proportion of Patients With Response
Časové okno: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Overall Survival
Časové okno: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Overall survival is defined as time from randomization to death or date last known alive. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Immunohistochemistry (IHC) and Response
Časové okno: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status was determined by IHC using paraffin-embedded sections of 4µm. A score (H-score) was generated based on the findings and scoring was performed by two pathologists. This H-score ranges from 0 (no staining in the tumor) to 300 (diffuse intense staining of the tumor). The highest score was used if there was disagreement. H-scores were grouped into 3 standard categories for MGMT status: Category 1 - <=50 Category 2 - 51-100 Category 3 - >100 |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Promoter Methylation and Response
Časové okno: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status is determined by promoter methylation, a clinically validated methylation-specific polymerase chain reaction (PCR) analysis. A tumor sample is considered positive for MGMT promoter methylation if an 80bp band is detected in the methylated PCR reaction. It would be considered MGMT negative if an 80bp band is not detected in the methylated PCR reaction. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Pamela Kunz, ECOG-ACRIN Cancer Research Group
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhadovaný)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
- Onemocnění endokrinního systému
- Novotvary podle místa
- Novotvary
- Novotvary podle histologického typu
- Novotvary trávicího systému
- Nemoci trávicího systému
- Novotvary endokrinních žláz
- Onemocnění slinivky břišní
- Novotvary, žlázové a epiteliální
- Adenokarcinom
- Adenom
- Karcinom
- Neuroektodermální nádory
- Novotvary, zárodečné buňky a embryonální
- Neuroendokrinní nádory
- Karcinom, Neuroendokrinní
- Novotvary pankreatu
- Adenom, Islet Cell
- Karcinom, buňka ostrůvků
- Gastrinom
- Inzulinom
- Glukagonom
- Somatostatinom
- Organické chemikálie
- Heterocyklické sloučeniny, 1 kruh
- Heterocyklické sloučeniny
- Azoly
- Nukleové kyseliny, nukleotidy a nukleosidy
- Dacarbazine
- Triazenes
- Imidazoly
- Deoxycytidin
- Cytidin
- Pyrimidinové nukleosidy
- Pyrimidiny
- Nukleosidy
- Uracil
- Pyrimidinony
- Deoxyribonukleosidy
- Fluorouracil
- Temozolomid
- Kapecitabin
Další identifikační čísla studie
- E2211
- U10CA180820 (Grant/smlouva NIH USA)
- U10CA021115 (Grant/smlouva NIH USA)
- E2211 (Jiný identifikátor: ECOG-ACRIN Cancer Research Group)
- NCI-2012-02007 (Identifikátor registru: CTRP (Clinical Trial Reporting Program))
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .